Data / Form D filings / TearClear Corp.
TearClear Corp.: Form D filings
TearClear Corp., a pharmaceuticals company in Princeton, NJ, filed 10 Form D notices with the SEC between 2017 and 2023. The latest, on July 13, 2023, reports $11.8 million sold of a $16 million offering to 70 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3495 US Hwy 1, 34 Ste1164, Princeton, NJ, 08540
- Phone
- (617) 454-7251
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1706975
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 13, 2023 | New notice | $15,961,748 | $11,764,262 | $4,197,486 | 70 | Jun 29, 2023 | sec.gov |
| Aug 16, 2022 | Amendment | $10,000,000 | $5,900,000 | $4,100,000 | 43 | Apr 18, 2022 | sec.gov |
| Apr 27, 2022 | New notice | $10,000,000 | $5,000,000 | $5,000,000 | 40 | Apr 18, 2022 | sec.gov |
| Aug 19, 2020 | Amendment | $25,967,377 | $22,346,503 | $3,620,874 | 51 | Apr 15, 2020 | sec.gov |
| Jul 23, 2020 | Amendment | $25,967,377 | $22,246,504 | $3,720,873 | 50 | Apr 15, 2020 | sec.gov |
| Apr 28, 2020 | New notice | $25,967,377 | $15,779,678 | $10,187,699 | 39 | Apr 15, 2020 | sec.gov |
| Feb 14, 2020 | New notice | $3,000,000 | $2,790,000 | $210,000 | 32 | Jan 31, 2020 | sec.gov |
| Feb 14, 2019 | New notice | $5,000,000 | $4,999,999 | $1 | 22 | Feb 1, 2019 | sec.gov |
| May 31, 2017 | Amendment | $4,631,151 | $4,631,149 | $2 | 11 | May 11, 2017 | sec.gov |
| May 19, 2017 | New notice | $4,631,151 | $2,386,149 | $2,245,002 | 9 | May 11, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard Heinick | Director | |
| Tyler Stowater | Director | |
| Stuart Raetzman | Director | |
| Srini Venkatesh | Executive Officer | |
| Richard Harrison | Executive Officer | |
| William Link | Director | |
| Jeffry Weinhuff | Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Jul 10, 2023 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TearClear Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.